16. Leukemia Cytochemistry Flashcards
Neoplasm
- “new growth”
- Result of unregulated proliferation of a single transformed cell
- benign or malignant
Leukemia
- Malignant bone marrow neoplasm
- Abnormal cells are present in both the bone marrow and the peripheral circulation
Myeloid
- granulocytes (neutrophils, eosinophils, basophils)
- monocytes
- erythrocytes (RBC)
- platelets
ACUTE LEUKEMIAS
- Abrupt onset
- Death in weeks or months if not treated
- All ages affected
Blasts > 30% (FAB) > 20% (WHO) - WBC counts-inc(50%), nl(25%), dec(25%)
- Anemia, neutropenia, and thrombocytopenia
CHRONIC LEUKEMIAS
- Insidious onset
- Mostly adults
- More mature cells
- Death in years usually
- WBC count usually very elevated
- Organomegaly-extramedullary hematopoiesis
Leukemia – Most Common Age Group
- ALL-children
- CLL-older adults
- CML-young to middle age adults
- AML-infants50 years of age
Chromosomal Abnormalities
Oncogenes
- Genes that are associated with dominant-acting cancer mutations
- Transforms cells into a malignant phenotype
Tumor supressor genes
- Code for protein that resist malignant transformation
- Loss is associated with malignancies
Leukemia Affect on Molecular Pathways
- Arrested differentiation
- t(15:17) found in acute promyelocytic leukemia
- Transcriptional repression
- Disruptions of cell signaling
- BCR-ABL fusion gene in chronic myeloproliferative neoplasms
- Progression
- Apoptosis
Hereditary Abnormalities Genetic Susceptibility
Associated with abnormal chromosome number or chromosomal instability
- Down’s syndrome - 20x increase risk of leukemia
- Kleinfelter syndrome
Environmental Factors
of Leukemia
- Radiation exposure: nuclear reactions, therapeutic radiation, occupational exposure
- Drugs
- Chemicals: Chloramphenicol, Arsenic, Insecticides, Benzene
- Viruses: Retro viruses
[HTLV-I, II, V (Human T-Cell Leukemia/ lymphoma virus
HIV-1 (Human Immunodeficiency Virus)], EBV – Burkitts Lymphoma
Clinical Findings
of Leukemia
- Anemia: fatigue, pallor
- Granulocytopenia: fever, infection
- Thrombocytopenia: bruising, bleeding
Examples of Laboratory Evaluation for Leukemia
- CBC
- Peripheral blood smear
- Bone marrow aspirate/biopsy
- Cytochemistry
- Flow cytometry (Immunophenotyping)
- Cytogenetics
CDC of Leukemia
- Anemia: mild to severe, normocytic, normochromic
- Platelet counts: decreased
- WBC - variable
Peripheral Smear of Leukemia
- MAY reveal blasts or other immature cells
- Circulating nRBC
- Other dysplastic features: Hypogranlation,
Pelger Huet cells (hyposegmentation)
Bone Marrow Aspirate/Biopsy
- Presence of blasts (%)
- Morphology
- Cellularity, other elements (is there a 3:1 ratio?)
Immunophenotyping
- Immunologic technique using monoclonal antibodies to identify Antigens on cells.
- An International team designed a nomenclature system for Antibodies that have the same specificity (Cluster of Designation). Each cluster is assigned a number.[Example (CD 33, CD 34) etc….]
Cytogenetics
- looking at chromosome, DNA, karyotype
Involved in:
- Diagnosis
- Classification
- Prognosis
- Treatment
Cytochemistry
- The in vitro staining of cells that allows microscopic examination of the cell’s chemical composition
- Help to differentiate the lineage of immature cells
Cytochemical Stain
- Cells are incubated with substrates that react with specific chemical constituents
- If the specific constituent is present, it’s reaction is confirmed by the formation of a colored product within the cell
- Samples : Peripheral blood film, Bone marrow aspirate, Biopsy touch preps
Sudan Black B
- Stains lipids, phospholipids, neutral fats, sterols
- Granulocytes: membranes of both primary and secondary granules stain intensely
- Auer rods +++
- Monocytes – weakly positive
- Lymphocytes - negative
- Used to differentiate AML from ALL
Myeloperoxidase Stain
- similar to SBB
- Identifies the sites of myeloperoxidase activity
- Granulocytes intensely positive
- Monocytes weakly positive
- Lymphocytes negative
- Used to differentiate AML from ALL
Chloroacetate (specific) esterase
- similar to SBB and MPO
- Identifies site of chloroacetate esterase activity
- Specific for granulocytic series
- Monocytic series negative to weakly positive
- Lymphocytic cells are negative
- Differentiates AML from ALL
Alpha naphthol (non-specific) esterase stain
- Identifies alpha naphthol esterase activity primarily in monocytes
- Very weak or absent activity in granulocytes, megakaryocytes, lymphocytes
- Used to diagnose Myelomonocytic (M4) and Monocytic (M5) leukemias
Periodic Acid-Schiff (PAS) Stain
- Stains glycogen and glycols in mature granulocytes, platelets, megakaryocytes and monocytes
- Early myeloid cells are negative
- Normal erythroid precursors are negative
- M6 erythroblasts stain positive
- ALL lymphoblasts may have coarse block-like positivity
Leukocyte Alkaline Phosphatase Stain (NAP)
- aka Neutophil Alkaline Phosphatase Stain (NAP)
- Identifies enzyme activity in secondary granules of mature neutrophils (beginning at the metamyelocyte stage)
- Not present in eosinophils or basophils
- Positivity is scored 0 – 4+
- Used to differentiate CML from Leukemoid Reaction
NAP Scores:
- Normal – approx 50-150
- Decreased – CML, PNH
- Increased – Leukemoid Reaction (severe infection), Polycythemia Vera
Acid Phosphatase Stain
- Most cells have some activity
- Hairy cells are strongly positive and not inhibited by tartrate = TRAP positive (Tartrate resistant)
Terminal Deoxynucleotidyl Transferase (TdT)
- Rabbit anti-TdT + Goat anti-rabbit-FITC
- Look for nuclear fluorescence
- Marker for immature lymphocytes
- No peripheral blood cells positive normally
Factor VIII Stain
- Immunocytochemical stain that gives positive results in megakaryoblastic leukemias
- Uses antibodies directed against Factor VIII contained in platelet precursors
- Some labs use antibodies against platelet glycoproteins
Acute Megakaryocytic Leukemia
- Immunoperoxidase staining (brown) for Factor VIII related protein identifies the blasts as being of megakaryocyte lineage
Treatments of Leukemia
- Chemotherapy
- Radiation therapy
- Targeted therapy: Monoclonal antibodies target specific antigens on malignant cells
- Stem Cell Transplantation